Cargando…
A complicated liaison: IL-33 and IL-33R in arthritis pathogenesis
Interruption of cytokine signaling, by targeting either the cytokine itself or its cellular receptor, is a mainstay in the therapy for patients with rheumatic diseases. Interleukin (IL)-33, a member of the IL-1 cytokine family, has emerged as an important mediator of inflammatory responses. In a sid...
Autores principales: | Kamradt, Thomas, Drube, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672742/ https://www.ncbi.nlm.nih.gov/pubmed/23638884 http://dx.doi.org/10.1186/ar4209 |
Ejemplares similares
-
IL‐3 is essential for ICOS‐L stabilization on mast cells, and sustains the IL‐33‐induced RORγt(+) T(reg) generation via enhanced IL‐6 induction
por: Drube, Sebastian, et al.
Publicado: (2021) -
The IL-33-induced p38-/JNK1/2-TNFα axis is antagonized by activation of β-adrenergic-receptors in dendritic cells
por: Helbig, Christiane, et al.
Publicado: (2020) -
ATP/IL‐33‐triggered hyperactivation of mast cells results in an amplified production of pro‐inflammatory cytokines and eicosanoids
por: Jordan, Paul M., et al.
Publicado: (2021) -
Contribution of IL-33 to the Pathogenesis of Colorectal Cancer
por: Cui, Guanglin, et al.
Publicado: (2018) -
Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid Arthritis
por: Hong, Yeon-Sik, et al.
Publicado: (2011)